Quick Takeaways
- IBIO - iBio, Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q4 2025.
- Headline metric: Return On Equity -70%.
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-02-09) highlights Return On Equity -70.2%, Return On Assets -37.0%, and Operating Margin -8491.0%.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
17.5/100
Weak Confidence high
-70%
Metric score 0.0/100
-37%
Metric score 0.0/100
Debt-to-equity
Return On Equity, Return On Assets, and Operating Margin
Return On Equity
-70%
YoY: -58%
Industry median: -43% (n=675)
Return On Assets
-37%
YoY: -17%
Industry median: -47% (n=673)
Operating Margin
-8491%
YoY: +9.1%
Industry median: -121% (n=298)
Current Ratio
9.04x
YoY: +414%
Industry median: 3.39x (n=667)
Quick Ratio
8.93x
YoY:
Industry median: 1.51x (n=289)
Debt-to-equity
0.04x
YoY: -62%
Industry median: 0.26x (n=530)
Revenues YoY
-100%
YoY:
Industry median: 7.3% (n=302)
NetIncomeLoss YoY
-28%
YoY:
Industry median: -0.93% (n=641)
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | -70% | -58% |
| Return On Assets | -37% | -17% |
| Operating Margin | -8491% | +9.1% |
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 9.04x | +414% |
| Quick Ratio | 8.93x | |
| Debt-to-equity | 0.04x | -62% |
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -100% | |
| NetIncomeLoss YoY | -28% |
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 34,543,561 | +250% |
| Common Stock, Shares, Outstanding | 30,053,070 | +228% |
| Common Stock, Value, Issued | $30,000 | +233% |
| Weighted Average Number of Shares Outstanding, Basic | 99,133,000 | +986% |
| Weighted Average Number of Shares Outstanding, Diluted | 99,133,000 | +986% |
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.